The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.023
Bid: 0.023
Ask: 0.027
Change: 0.003 (13.64%)
Spread: 0.004 (17.391%)
Open: 0.0249
High: 0.025
Low: 0.023
Prev. Close: 0.022
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EUR 8bn Funding Agreement with Bank acquisition

21 Sep 2020 07:00

RNS Number : 5074Z
Supply @ME Capital PLC
21 September 2020
 

21 September 2020

Supply@ME Capital plc

(The "Company", "SYME" or "Supply@ME")

Strategic inventory funding agreement for up to €8bn over five years

with acquisition of Bank in Europe

 

Supply@ME Capital plc, the innovative fintech platform which provides a unique, market leading Inventory Monetisation© service to European manufacturing and trading companies, is pleased to announce that it has entered into a strategic agreement ("Agreement") with a leading European Alternative Investment Firm (the "Financial Partner") and SYME's shareholders, 1AF2 S.r.l. and The AvantGarde Group S.p.A. ("Co-investors"), to acquire a bank in Europe (the "Bank"). The core objective of the transaction is to support and facilitate the rapid growth of the Supply@ME platform, with the full support of the Central Bank within that jurisdiction.

 

As part of the Agreement, Supply@ME will give the Bank pre-emption rights to invest in each securitisation note issue and other funding programmes, to support the Platform as it grows. In return, the Bank will provide up to €8bn of funding over five years, to support inventory funding across all of SYME's international operations. The Financial Partner has committed to recapitalise the Bank immediately following the completion of the Central Bank's regulatory banking authorisation process.

The Agreement delivers on the following strategic objectives:

- the Bank will remain independent, owned by the Financial Partner and the Co-investors. Supply@ME will not be a Bank shareholder and it has no costs relating to the transaction. Control of key operational roles will be given to The AvantGarde Group who will be responsible for selecting the Bank's CEO, whilst governance supervision will be overseen by the Financial Partner

 

- the Bank will provide "banking-as-a-service" to Supply@ME in relation to:

o subscribing to all funding note issuances in line with the Bank's capital adequacy targets which have already been agreed,

o funding across Supply@ME Group's international operating regions, subject to country specific banking licence restrictions, and

o co-investing with institutional investors in securitisation notes issued by the Platform, in order to provide additional funds for inventory monetisation, in accordance with the Company's multi-channel funding strategy

 

- the Bank's indicative cumulative inventory funding targets are estimated at:

o €4bn by the end of 2021

o €5.5bn end 2022

o €7bn end 2023

o €8bn end 2024

 

- the funding costs to Supply@ME will be lower than the current costs borne by the Platform for its "open funding" securitisation

 

- the Bank will also be the "partner and banker of trust" for SYME, whereby all bank accounts set up for inventory monetisation transactions will be held at the Bank. This will serve to reinforce monitoring processes, digital integration and security

 

- the Bank can hold up to 2% of SYME share capital, including purchases through the market subject to MAR and other regulatory approvals

 

The Central Bank regulatory approval processes relating to the acquisition of the Bank are underway with the support of the local banking regulator. However, until such regulatory and contractual processes have been completed, the parties have stipulated that the name of the Bank and Financial Partner cannot be announced. The Financial Partner is a regulated investment manager in Europe which operates in the private equity and private debt markets. It has raised and invested more than €2 billion from institutional and retail investors.

The impact of the Agreement on the current business plan of Supply@ME is transformational. The completion of the acquisition of the Bank will facilitate a major increase in the quantum and speed of the Platform's estimated capital inflows for inventory monetisation, since securitisation notes and other funding structures can now be subscribed by SYME's partner Bank. Specifically:

- an increase of target inventory funding from the initial business plan's €4bn, to at least €8bn at the end of the business plan period in 2024

- exceeding the 2020-2021 (year-end Sept 21) EBITDA target

- more rapid expansion within the Platform's target geographic areas

- enhancement of the servicing fee net margin (the difference between client company fee received by SYME' Stock Company and the operating and finance costs of the securitisation notes) from approximately 2% to 3% of the total value of inventory monetised. This implies a potential profit margin improvement of approximately 50%

- given the more competitive funding rates that will be made available to SYME, an ability to offer lower client company servicing fees, on a risk adjusted basis, to higher investment grade companies

- banking support from SYME's partner Bank for client company due diligence activities to further accelerate the on-boarding processes and scale-up of the business

 

Following this significant upgrade to funding, through its "banking as a service" strategic partner, SYME will be able to accelerate the funding initiatives previously announced as follows:

- the Bank partnership will fast-forward the funding of inventory monetisation for those client companies which do not form part of the initial StormHarbour €300m portfolio

- it will deliver additional inventory funding in the UK working together with its UK capital markets partner on the first portfolio of UK Client companies

- it will enable improvements to the self-funding agreements being negotiated with two Italian banks, to create more synergies and integrations with SYME's new partner Bank

- the Company can now analyse new financing structures using direct borrowing lines from the Bank to monetise inventory (and consequently increase monetisation to above €8bn), whereby securitisation notes could be structured in tranches (a senior lower risk tranche for institutional investors, and, a junior first-loss higher risk tranche for the Bank)

 

Alessandro Zamboni, SYME CEO, commented "This strategic Bank partnership is a significant addition to the Company's existing funding initiatives. Our objective has always been to form partnerships that would enable us to exceed our funding targets, and this agreement achieves that at one stroke. Our business model is highly scalable, subject to access to capital, and to client companies. With this new Bank partnership and the other on-track initiatives, we now have capital and client companies.

"We are moving into an economic environment where recapitalisation of companies and other forms of capital injection, such as inventory monetisation, will need to be considered. SYME provides a service that is comparable to an equity recapitalisation with better funding costs and the absence of any equity dilution. Our new Bank partnership will mean that we have two important key barriers to entry protecting us in this untapped inventory monetisation market: a unique capability to analyse and monitor inventory, and a competitive cost of funding through which to monetise it. We're delighted with this big step forward and are enthusiastic to push ahead with the next phase of SYME."

This Announcement contains Inside Information as defined under the Market Abuse Regulation (EU) No. 596/2014.

Notes

Supply@ME enables businesses to generate cashflow, without incurring debt, by monetising their existing stock. Before a business has found an end-customer for its inventory, the Supply@ME platform enables them to sell ("monetise") their stock and receive cash immediately to boost their working capital. The Supply@ME service enables strong companies to improve their working capital cycle. SYME does not monetise inventory for companies in financial difficulty or with inventory that they are struggling to sell.

 

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited: +44 (0)20 7933 8780

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRFBLLLBKLBBBL
Date   Source Headline
10th May 202411:47 amRNSPublication of the 2023 Annual Report and Accounts
9th May 20245:02 pmRNSIndependent Auditor's Report
1st May 20247:00 amRNS2023 Annual Report and Accounts
29th Apr 202412:27 pmRNSAgreement signed to launch a IM programme
5th Apr 20247:00 amRNSBusiness update
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTransfer of Warrants
27th Mar 20247:00 amRNSTransaction of a Person Closely Associated
22nd Mar 20247:00 amRNSPDMR/PCA shareholding: stock loans update
29th Feb 20247:00 amRNSBusiness, trading and funding update
19th Feb 20247:00 amRNSExercise of warrants, issue of equity and TVR
26th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20247:00 amRNSExercise of warrants, issue of equity and TVR
3rd Jan 20247:00 amRNSWhite-Label IM Agreement - funding secured
5th Dec 20238:40 amRNSFunding and Business update
23rd Nov 20237:00 amRNSTransfer of Warrants
6th Nov 20237:00 amRNSExercise of Warrants, issue of equity and TVR
1st Nov 20238:58 amRNSTotal Voting Rights
10th Oct 20237:00 amRNSExercise of Warrants, issue of equity and TVR
29th Sep 20237:00 amRNSHalf-year Report
25th Sep 20237:00 amRNSExercise of Warrants, issue of equity and TVR
12th Sep 20237:00 amRNSExercise of Open Offer Warrants
1st Sep 20237:00 amRNSTotal Voting Rights
17th Aug 20237:00 amRNSExercise of options, issue of equity and TVR
4th Aug 202312:34 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSTotal Voting Rights
7th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20237:00 amRNSExercise of Warrants, issue of equity and TVR
3rd Jul 20237:00 amRNSExecution of first UK IM using traditional funding
30th Jun 20235:36 pmRNSHolding(s) in Company
30th Jun 202312:54 pmRNSTotal Voting Rights
30th Jun 20237:00 amRNSTransaction of a Person Closely Associated
23rd Jun 20235:37 pmRNSResult of General Meeting
23rd Jun 20235:36 pmRNSResult of AGM
15th Jun 202311:00 amRNSReplacement Total Voting Rights
15th Jun 20238:00 amRNSNew Italian PNP regulation comes into effect
13th Jun 20237:00 amRNSExercise of Warrants, issue of equity and TVR
9th Jun 20237:00 amRNSFirst UK IM transaction from traditional funding
5th Jun 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
2nd Jun 202312:51 pmRNSHolding in Company
31st May 20233:56 pmRNSNotice of GM of Open Offer Warrantholders
31st May 20233:55 pmRNSNotice of Annual General Meeting
26th May 20237:00 amRNSAdmission of Shares and Total Voting Rights
23rd May 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
22nd May 20237:00 amRNSGrant of Awards under the Supply@ME LTIP
19th May 20231:40 pmRNSHolding(s) in Company
16th May 20237:00 amRNSInvestor Presentation via Investor Meet Company
9th May 20233:03 pmRNSHolding(s) in Company
5th May 20237:00 amRNSExecution of first IM from traditional funding
4th May 202312:40 pmRNSAdmission and Exercise of Open Offer Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.